FOM Technologies listed
on Nasdaq First North.

Welcome to the investor information site
of FOM Technologies.

Velkommen til investor informations siden
for FOM Technologies.

On this site, we have gathered all information, relevant for current and potential investors. We hope that you’d like to join our growth journey!

På denne side har vi samlet al den information, vi har vurderet, vil være relevant for nuværende såvel som potentielle investorer. Vi håber du vil være med på vores vækstrejse!

SHARE PRICE/AKTIE KURS

See FOM Technologies share price on Nasdaq.
Se FOM Technologies aktiekurs på Nasdaq.

SHARE PRICE ON NASDAQ

Investor portal/Investor portal

The Investor Portal allows you to view your personal share information and change your contact information. Both a Danish and an English version of the Investor Portal is available.

Shareholders are encouraged to sign up and register their email address.

Log-on to the investor portal and register your email – all investor related information is shared digitally.

Investorportalen giver mulighed for at se sine personlige aktieoplysninger og ændre sine kontaktoplysninger. Både en dansk og en engelsk version af investorportalen er tilgængelig.

Aktionærer opfordres til at tilmelde sig og registrere deres e-mail adresse.

Log på investorportalen og registrer din e-mail – alle investorrelaterede informationer sendes digitalt.

ENGLISH INVESTOR PORTAL

DANSK INVESTOR PORTAL

COMPANY ANNOUNCEMENTS/SELSKABSMEDDELELSER

FINANCE CALENDAR/FINANS KALENDER

FINANCIAL YEAR: 2021/FINANSIELT ÅR: 2021

Date/Dato	Event/Begivenhed
February 11, 2021	Deadline for general assembly proposals 2021
February 25, 2021	Annual report 2020
March 11, 2021	General assembly 2021
August 27, 2021	Half-year report: H1 2021

FINANCIAL YEAR: 2022/FINANSIELT ÅR: 2022

Date/Dato	Event/Begivenhed
Pending	Deadline for general assembly proposals 2022
Pending	Annual report 2021
Pending	General assembly 2022
Pending	Half-year report: H1 2022

SUBSIDIARY/DATTERSELSKAB

FOM Technologies owns a 51% stake in MLMC Therapeutics ApS.
FOM Technologies ejer en 51% andel i MLMC Therapeutics ApS.

MLMC Therapeutics website

FINANCIAL REPORTS/FINANSIELLE REPORTER